Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myomo (MYO) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Myomo (MYO) over the last 10 years, with Q3 2025 value amounting to $42.2 million.

  • Myomo's Shares Outstanding (Weighted Average) rose 1111.34% to $42.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.2 million, marking a year-over-year increase of 1111.34%. This contributed to the annual value of $37.8 million for FY2024, which is 2799.89% up from last year.
  • Myomo's Shares Outstanding (Weighted Average) amounted to $42.2 million in Q3 2025, which was up 1111.34% from $41.6 million recorded in Q2 2025.
  • Myomo's Shares Outstanding (Weighted Average)'s 5-year high stood at $42.2 million during Q3 2025, with a 5-year trough of $5.2 million in Q1 2021.
  • For the 5-year period, Myomo's Shares Outstanding (Weighted Average) averaged around $23.3 million, with its median value being $28.0 million (2023).
  • In the last 5 years, Myomo's Shares Outstanding (Weighted Average) surged by 39922.74% in 2023 and then surged by 761.11% in 2024.
  • Myomo's Shares Outstanding (Weighted Average) (Quarter) stood at $5.8 million in 2021, then grew by 20.94% to $7.1 million in 2022, then skyrocketed by 318.34% to $29.5 million in 2023, then grew by 28.0% to $37.8 million in 2024, then increased by 11.68% to $42.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $42.2 million for Q3 2025, versus $41.6 million for Q2 2025 and $41.5 million for Q1 2025.